MedicalSystem Biotechnology Co Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MedicalSystem Biotechnology Co Ltd with three other
companies in this sector in China:
Shanghai Kehua Bio-Engineering Co., Ltd.
sales of 1.59 billion Chinese Renmimbi [US$232.79 million]
of which 100%
was Diagonistic Products),
DA AN Gene Co.,Ltd. Of Sun Yat-Sen University
(1.54 billion Chinese Renmimbi [US$225.23 million]
of which 95%
was Biological Products), and
Maccura Biotechnology Co Ltd
(1.97 billion Chinese Renmimbi [US$287.68 million]
of which 50%
was Agent reagent).
MedicalSystem Biotechnology Co Ltd reported sales of 1.81 billion Chinese Renmimbi (US$263.61 million)
December of 2017.
increase of 71.1%
versus 2016, when the company's sales were 1.05 billion Chinese Renmimbi.
Sales at MedicalSystem Biotechnology Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 451%).